Brian Feth, Jonathan Grinstein, PhD, Beth Willers, and Laks Pernenkil go behind the headlines to discuss major news announcements made during the JP Morgan Healthcare Conference, a wave of new ...

CHMP has granted Eisai Europe and Biogen a positive opinion for the use of their monoclonal antibody therapy in treating early Alzheimer’s disease.

Under the agreement, the companies will advance development of IBI3009, Innovent’s ADC candidate, which has received IND approvals in the US, China, and Australia.

AbbVie's latest acquisition target is Nimble Therapeutics, which will give AbbVie a lead asset, an oral peptide for treating psoriasis.

It is important to understand the differences between risk-based decision making and other decision making in a pharmaceutical quality system.

Optimizing Drug Packaging: Strategic Approaches for De-Risking Drug Development ...

Optimizing Drug Packaging: Strategic Approaches for De-Risking Drug Development ...